Rankings
▼
Calendar
LUNG
Pulmonx Corporation
$75M
Q2 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$21M
+20.9% YoY
Gross Profit
$15M
73.7% margin
Operating Income
-$16M
-75.2% margin
Net Income
-$15M
-73.7% margin
EPS (Diluted)
$-0.39
QoQ Revenue Growth
+10.2%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$173M
Total Liabilities
$71M
Stockholders' Equity
$101M
Cash & Equivalents
$63M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21M
$17M
+20.9%
Gross Profit
$15M
$13M
+20.2%
Operating Income
-$16M
-$16M
+5.0%
Net Income
-$15M
-$16M
+5.4%
Geographic Segments
UNITED STATES
$14M
67%
EMEA
$6M
29%
Asia Pacific
$802,000
4%
Other International Geographical Areas
$139,000
1%
← FY 2024
All Quarters
Q3 2024 →
LUNG Q2 2024 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena